EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Real-world Experience with New Systemic Agents for Atopic Dermatitis in the Netherlands

Anne R Schlösser, A C M Lia Kunkeler, Dirk Jan Hijnen

Immunology and Allergy Clinics of North America · 2025

DOI: 10.1016/j.iac.2025.06.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology and Allergy Clinics of North America, 2025. Verfasst von Anne R Schlösser und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Janus Kinase Inhibitors, Biological Products. Die Arbeit nennt 99 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by severe itch, significantly affecting patients' quality of life. Increased understanding of the underlying pathomechanism has led to the development of effective new systemic treatments, including biologics and Janus kinase inhibitors. However, responses to these new treatments vary among patients, highlighting the need for personalized approaches. This article provides an overview of AD's epidemiology, pathogenesis, and management strategies, focusing on the effectiveness and safety of new systemic treatments and patient-centered dosing regimens. It also explores future biomarker predictions and discusses new systemic treatments currently in development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicJanus Kinase InhibitorsBiological ProductsHumansNetherlandsQuality of LifeBiomarkersTreatment OutcomeDisease Management

Stichwörter der Autor:innen

Atopic dermatitisBiologicsDaily practiceImmunosuppressantsJAK inhibitors

Substanzen

Janus Kinase InhibitorsBiomarkersBiological Products

Autor:innen und Institutionen

  • Department of Dermatology, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
  • Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: dirkjan.hijnen@radboudumc.nl.

Zitieren

APA

Schlösser, A. R., Kunkeler, A. C. M. L., & Hijnen, D. J. (2025). Real-world Experience with New Systemic Agents for Atopic Dermatitis in the Netherlands. Immunology and Allergy Clinics of North America. https://doi.org/10.1016/j.iac.2025.06.008

Vancouver

Schlösser AR, Kunkeler ACML, Hijnen DJ. Real-world Experience with New Systemic Agents for Atopic Dermatitis in the Netherlands. Immunology and Allergy Clinics of North America. 2025. doi:10.1016/j.iac.2025.06.008

BibTeX
@article{Schlsser2025,
  author = {Schlösser, Anne R and Kunkeler, A C M Lia and Hijnen, Dirk Jan},
  title = {Real-world Experience with New Systemic Agents for Atopic Dermatitis in the Netherlands},
  journal = {Immunology and Allergy Clinics of North America},
  year = {2025},
  doi = {10.1016/j.iac.2025.06.008}
}
Kostenlos starten →